Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?

Paul Glasziou; Simon Eckermann; Sarah Mulray; R Simes; Andrew Martin; Adrienne Kirby; Jane Hall; Susan Caleo; Harvey White; Andrew Tonkin

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?

Paul Glasziou, Simon Eckermann, Sarah Mulray, R Simes, Andrew Martin, Adrienne Kirby, Jane Hall, Susan Caleo, Harvey White, Andrew Tonkin

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	420-426
Number of pages	7
Journal	Medical Journal of Australia
Volume	177
Issue number	8
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{dc3200f003e849ce91a89dc36f9e259f,

title = "Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: Is it cost-effective?",

author = "Paul Glasziou and Simon Eckermann and Sarah Mulray and R Simes and Andrew Martin and Adrienne Kirby and Jane Hall and Susan Caleo and Harvey White and Andrew Tonkin",

year = "2002",

language = "English",

volume = "177",

pages = "420--426",

journal = "Medical Journal of Australia",

issn = "0025-729X",